Financial Symmetry Inc Provectus Biopharmaceuticals, Inc. Call Options Transaction History
Financial Symmetry Inc
- $143 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PVCT
# of Institutions
7Shares Held
227KCall Options Held
0Put Options Held
0-
Home Federal Bank Of Tennessee100KShares$12,0000.0% of portfolio
-
Lee Danner & Bass Inc50KShares$6,0000.0% of portfolio
-
Atlas Wealth LLC Cincinnati, OH26.6KShares$3,1940.0% of portfolio
-
Lbmc Investment Advisors, LLC20KShares$2,4000.0% of portfolio
-
Academy Capital Management Inc Waco, TX20KShares$2,4000.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $50.3M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...